Benfluorex and unexplained valvular heart disease: a case-control study.
<h4>Background</h4>Recent case reports suggest that benfluorex, a fenfluramine derivative used in the management of overweight diabetic patients and dyslipidemia, is associated with cardiac valve regurgitation.<h4>Methods</h4>We conducted a case-control study. Eligible patien...
Guardado en:
Autores principales: | Irène Frachon, Yves Etienne, Yannick Jobic, Grégoire Le Gal, Marc Humbert, Christophe Leroyer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/783878fcc1a94d1eb71fc3cc69bea834 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Three dimensional echocardiography in valvular heart disease
por: Justin M.S. Lee, et al.
Publicado: (2017) -
Advances in Transcatheter Electrosurgery for Treating Valvular Heart Disease
por: Jaffar M Khan, et al.
Publicado: (2021) -
When to use stress echocardiography in the evaluation of patients with valvular heart disease
por: Vuyisile T. Nkomo, et al.
Publicado: (2017) -
The implications of HIV infection on the management of valvular heart disease in Southern Africa
por: D.P. Naidoo, et al.
Publicado: (2017) -
Exercise Right Heart Catheterisation in Cardiovascular Diseases: A Guide to Interpretation and Considerations in the Management of Valvular Heart Disease
por: Felipe H Valle, et al.
Publicado: (2021)